Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

386477

	registered interest
	date	30/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to ensure that NHS England provides patients with hepatitis C access to new drugs approved by the National Institute for Health and Care Excellence without delay, and to ensure that NHS England continues to assess new technologies based on cost-effectiveness rather than affordability.
	tabling member printed	Baroness Randerson
	uin	HL972
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Commissioners are legally required to fund drugs and treatments recommended in National Institute for Health and Care Excellence (NICE) technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>In the absence of guidance from NICE, it is for commissioners, including NHS England, to make funding decisions based on the available evidence.</p><p> </p><p> </p><p> </p><p>Commissioners are required to have in place clear and transparent arrangements for local decision making and for considering individual funding requests taking into account patients’ clinical circumstances.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:51 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

386476

	registered interest
	date	30/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when Public Health England's programme of work on liver disease will be published.
	tabling member printed	Baroness Randerson
	uin	HL971
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Public Health England’s liver disease framework will be published in autumn 2015.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:16 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

529955

	registered interest
	date	29/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Shipping: Inspections
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what guidance they have issued to ensure that HIV clinics also test patients annually for hepatitis C.
	tabling member printed	Baroness Randerson
	uin	HL882
	answer	answer is ministerial correction date of answer 12/07/2016 answer text <p>In February 2014 the British Association for Sexual Health and HIV (BASSH) convened an expert working group, including representation from Public Health England, to formally review evidence and produce <em>Recommendations for testing for sexually transmitted infections (STIs) men who have sex with men (MSM). </em>The recommendations are attached.</p><p> </p><p>The National Institute for Health and Care Excellence has also published <em>Hepatitis B and C testing - people at risk of infection</em>, recommending testing to all services users at increased risk of infection. A copy of the guidance is attached.</p> answering member printed Lord Prior of Brampton attachment 1 file name Hepatitis B and C testing - People at risk of infection.pdf title Hepatitis B and C testing - people at risk 2 file name Recommendations for testing for Sexually Transmitted Infections in men who have sex with men.pdf title Recommendations question first answered 12/07/2016 15:22:11 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

529185

	registered interest
	date	28/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Public Expenditure: South Wales
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what was NHS England's expenditure on all specialised services, disaggregated by different condition areas, in the last financial year, and what is their planned expenditure for the current year.
	tabling member printed	Baroness Randerson
	uin	HL839
	answer	answer is ministerial correction date of answer 07/07/2016 answer text <p>Planned spend figures for specialised commissioning by NHS England at programme of care level are not generally available. However, the hepatitis C budget for 2016/17 has been published and is £191 million.</p><p> </p><p>Actual spend levels by NHS England are analysed to provide a breakdown for the previous year. An exercise to establish these figures is due to begin shortly.</p><p> </p><p>Services for Multiple Sclerosis are commissioned mainly by clinical commissioning groups and spend data is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL838 question first answered 07/07/2016 12:45:32 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

529184

	registered interest
	date	28/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Public Expenditure
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what was NHS England's expenditure in 2015–16 on (1) cancer, (2) HIV, (3) cystic fibrosis, (4) multiple sclerosis, and (5) hepatitis C, and what is the UK planned expenditure in 2016–17 on each.
	tabling member printed	Baroness Randerson
	uin	HL838
	answer	answer is ministerial correction date of answer 07/07/2016 answer text <p>Planned spend figures for specialised commissioning by NHS England at programme of care level are not generally available. However, the hepatitis C budget for 2016/17 has been published and is £191 million.</p><p> </p><p>Actual spend levels by NHS England are analysed to provide a breakdown for the previous year. An exercise to establish these figures is due to begin shortly.</p><p> </p><p>Services for Multiple Sclerosis are commissioned mainly by clinical commissioning groups and spend data is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL839 question first answered 07/07/2016 12:45:32 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

458655

	registered interest
	date	08/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 11 February (HL5795), what aspects of treatment provided by drugs and alcohol services are not funded by the NHS.
	tabling member printed	Baroness Randerson
	uin	HL6807
	answer	answer is ministerial correction date of answer 21/03/2016 answer text <p>All public funding for the treatment of hepatitis C virus (HCV) is provided by the National Health Service.</p><p> </p><p>Depending on local arrangements, drug and alcohol services commissioned by local authorities in England and funded from the Public Health Grant, may provide service users with aspects of HCV treatment. These would usually include initial testing and counselling, referring and supporting patients who test positive to engage with and complete HCV treatment provided by the NHS. They might also cover providing premises for NHS diagnosis and treatment to take place in the community.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 21/03/2016 12:21:55 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

458654

	registered interest
	date	08/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 11 February (HL5795), what is the value of payments made to Operational Delivery Networks (ODN) via the Commissioning and Quality Innovation payment network in (1) total, and (2) by ODN, for each of the last three financial years.
	tabling member printed	Baroness Randerson
	uin	HL6806
	answer	answer is ministerial correction date of answer 17/03/2016 answer text <p>Operational Delivery Networks (ODNs) provide expert specialist oversight of prescribing decisions on hepatitis C. They were established in August 2015, therefore funding information is only available for 2015/16.</p><p> </p><p>In 2015/16, funding has been approximately £2.5 million. The majority of this amount has been via a central allocation.</p><p> </p><p>It is not possible to confirm the payments made to each ODN for commercial reasons.</p><p> </p><p>NHS England is funding ODNs via Commissioning Quality and Innovation in 2016/17 and 2017/18.</p><p> </p><p> </p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 17/03/2016 11:56:28 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

458653

	registered interest
	date	08/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 11 February (HL5795), when NHS England's plan for future hepatitis C funding will be finalised, how many patients will be able to access hepatitis C treatment via NHS England's plan for future hepatitis C funding, and whether they will place in the Library of the House a copy of NHS England's plan once it is finalised.
	tabling member printed	Baroness Randerson
	uin	HL6805
	answer	answer is ministerial correction date of answer 21/03/2016 answer text <p>Based on the modelling produced by the National Institute for Health and Care Excellence, NHS England has set out the NHS planning assumptions for hepatitis C in March 2016 for the financial year 2016/17. We understand that this has been shared with Members of Parliament and noble Lords, operational delivery networks, pharmaceutical companies and other stakeholders.</p><p>An expected 6,500 patients will have been treated for the 12 months ending March 2016. NHS England and providers are planning for 10,000 patients to be treated in the 12 months from April 2016 to March 2017.</p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 21/03/2016 12:22:20 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

450491

	registered interest
	date	03/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether the collaborative commissioning arrangements for new hepatitis C medicines outlined in the report by NHS England<i> Improving Value for Patients from Specialised Care, Commissioning Intentions 2016/2017 for Prescribed Specialist Services</i> will include plans to ensure that the areas covered by Operational Delivery Networks and Clinical Commissioning Groups are coterminous.
	tabling member printed	Baroness Randerson
	uin	HL5853
	answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>NHS England has been supporting Operational Delivery Networks (ODNs) to identify the clinical commissioning groups (CCGs) that are relevant to their geography.</p><p> </p><p>In many cases boundaries are co-terminous and this will assist in communications. Where this is not the case, this will mean that CCGs, ODNs, and NHS England commissioning hubs will work across a wider footprint to collaborate on relevant matters.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 12:56:07 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

449713

	registered interest
	date	02/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether funding will be provided to NHS Trusts as part of the Operational Delivery Network model to fund hepatitis C treatment services through either (1) a block contract, or (2) a tariff.
	tabling member printed	Baroness Randerson
	uin	HL5795
	answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Operational Delivery Networks (ODNs) provide expert specialist oversight of prescribing decisions on hepatitis C. Funding has been provided via Commissioning and Quality Innovation Payment (CQUIN) and it is NHS England’s intention to continue with CQUIN funding in 2016/17 and 2017/18.</p><p> </p><p>When a patient attends NHS services for treatment of hepatitis C, their attendance is included in the national tariff.</p><p> </p><p>Depending on the specific nature of their healthcare need, their care may be paid for by clinical commissioning groups (CCGs) or by NHS England’s specialised services hubs according to coding and whether the care they receive is defined as a prescribed specialised service.</p><p> </p><p>Some patients may have aspects of their hepatitis C treatment provided by other services (such as drugs and alcohol services) which are not funded by the NHS.</p><p> </p><p>NHS England is the responsible commissioner for hepatitis C drugs. These are high cost drugs and so are excluded from the national tariff.</p><p> </p><p>NHS England’s plan for future hepatitis C funding is being finalised at the moment. As NHS England are working with ODN clinical leads to plan to ensure that patients with unmet clinical need are treated via hepatitis C ODNs in a planned way over the coming years.</p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:12:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson